Form 4: 89bio, Inc. Executive Harry H. Mansbach Reports Stock Transaction
SEC Form 4 Filing
Chief Medical Officer of 89bio, Inc., Harry H. Mansbach, reports disposition of shares to cover tax obligations.
Summary
- On February 9, 2025, Harry H. Mansbach, Chief Medical Officer of 89bio, Inc., disposed of 3,817 shares of common stock to cover tax withholding obligations.
- The transaction was executed at a price of $11.41 per share.
- Following the transaction, Mansbach directly owns 319,884 shares of 89bio, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/09/2025 | Date of stock transaction (disposal of shares). |
| 02/11/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.